Form D · Biotechnology
ANAPTYSBIO INC
San Diego, CA · CIK 0001370053
Offering snapshot reported Jul 24, 2015 · SEC filing
- Reported sold
- $40.8M Offering amount: $40.8M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 13, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 24, 2015 | Initial | $40,767,277 | No comparison | 19 | SEC filing |
| Oct 10, 2013 | Initial | $2,022,117 | No comparison | 12 | SEC filing |
| Oct 14, 2011 | Initial | $8,024,394 | No comparison | 8 | SEC filing |
| Feb 7, 2011 | Initial | $14,400 | No comparison | 1 | SEC filing |
| Oct 21, 2010 | Initial | $9,600 | No comparison | 1 | SEC filing |
| Aug 27, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 20, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 8, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 22, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 18, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 24, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 6, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-244446
Source: Form D, filed Jul 24, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tiba Aynechi | Director |
| Carol Gallagher | Director |
| Robert Hoffman | Executive |
| Kevin Kinsella | Director |
| Marco Londei | Executive |
| Heath Lukatch | Director |
| Heathe Lukatch | Director |
| Nicholas Lydon | Director |
| Nick Lydon | Director |
| J. Leighton Read | Director |
| Hollings Renton | Director |
| John Schmid | Director |
| Thomas Smart | Director, Executive |
| Hamza Suria | Director, Executive |
| James Topper | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10421 Pacific Center Court, Suite 200
San Diego, CA, 92121
San Diego, CA, 92121